ARCHIVE

• Drugstore Sales Up 15.8% in FY2002 Survey: JACDS
  February 24, 2003

• Suzuken to Expand Its Drug Production Business
  February 24, 2003

• List of Drugs Announced for 24th Quality Reevaluation
  February 24, 2003

• OTC NEWS IN BRIEF
  February 24, 2003

• Price Agreement Rate Slightly Higher than Last Year: FJPWA President
  February 24, 2003

• 52 Active Ingredients, 5 Formulations to Undergo Quality Reevaluation
  February 24, 2003

• DIAGNOSTIC NEWS IN BRIEF
  February 24, 2003

• Small, Mid-sized Makers Should Focus on Improved Drugs: Mr Seko of PMSRL
  February 24, 2003

• REGULATORY NEWS IN BRIEF
  February 24, 2003

• Mochida to Complete Self-supporting System by Splitting Off Its Core Businesses
  February 24, 2003

• Iressa Expert Committee Issues Interim Report
  February 24, 2003

• MEDICAL FACILITIES & NURSING CARE NEWS IN BRIE
  February 24, 2003

• WORLD NEWS IN BRIEF
  February 24, 2003

• BUSINESS NEWS IN BRIEF
  February 24, 2003

• NEW PRODUCTS
  February 24, 2003

• 5 Companies Planning to Apply for GE Versions of Mevalotin
  February 24, 2003

• WEBSITE NEWS
  February 24, 2003

• Takeda Presents Data on CCR5 Antagonist with Anti-HIV Activity
  February 24, 2003

• Sumitomo Is Positive about Merging: President Yokatsuka
  February 24, 2003

• Maintaining Double-digit Growth Rates: Mr Matsumoto of J&J
  February 24, 2003

ページ

• « 先頭
• ‹ Prev
• …
• 616
• 617
• 618
• 619
• 620
• 621
• 622
• 623
• 624
• …
• Next ›
• 最終 »